Tuna oligopeptide powder composition as well as preparation method and application thereof

A technology of tuna and oligopeptides, which is applied in the direction of preparation methods, applications, chemical instruments and methods of peptides, and can solve problems such as death

Inactive Publication Date: 2020-10-23
YANTAI JIAHUI MARINE BIOTECH CO LTD
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, taking allopurinol will produce various adverse reactions, such as itchy papules or urticaria, gastrointestinal reactions su

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tuna oligopeptide powder composition as well as preparation method and application thereof
  • Tuna oligopeptide powder composition as well as preparation method and application thereof
  • Tuna oligopeptide powder composition as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] The preparation of tuna oligopeptide powder composition:

[0047] In parts by weight, the formula of the tuna oligopeptide powder composition is as follows: 26 parts of tuna oligopeptide powder, 16.8 parts of fish collagen peptide powder, 16 parts of acerola juice powder, 15 parts of peach juice powder, 10 parts of fructooligosaccharide, 10 parts of erythritol, 3 parts of fucoidan, 1.2 parts of compound sour sweetener.

[0048] The compound sour sweetener is formulated from DL-malic acid, citric acid, sodium citrate, and sucralose in a ratio of 3:2:1:1.

[0049] Weigh the above raw and auxiliary materials in proportion, pass through a 60-mesh sieve in turn, transfer the sieved raw and auxiliary materials to the V-shaped mixer, turn on the power and automatically mix for 35 minutes, transfer the evenly mixed powder to the automatic quantitative packaging machine, adjust The measured value is 4g / bag, and it is automatically packed. The automatically packaged products ar...

Embodiment 2

[0051] The preparation of tuna oligopeptide powder composition:

[0052] The formula composition of described tuna oligopeptide powder composition is as follows: 25 parts of tuna oligopeptide powders, 16.5 parts of fish collagen peptide powders, 16.25 parts of Acerola fruit juice powders, 15 parts of peach juice powders, 12.5 parts of fructooligosaccharides, 7.5 parts of erythritol, 3 parts of chitosan oligosaccharide, and 1.0 part of compound sour sweetener.

[0053] The compound sour sweetener is formulated from DL-malic acid, citric acid, sodium citrate, and sucralose in a ratio of 3:2:1:1.

[0054] Weigh the above raw and auxiliary materials in proportion, pass through a 60-mesh sieve in turn, transfer the sieved raw and auxiliary materials to the V-shaped mixer, turn on the power and automatically mix for 35 minutes, transfer the evenly mixed powder to the automatic quantitative packaging machine, adjust The measured value is 4g / bag, and it is automatically packed. The ...

Embodiment 3

[0056] Effect of tuna oligopeptide powder on uric acid content in serum of mice with hyperuricemia:

[0057] Experimental animals: Kunming mice, SPF grade, 72 males, weighing 20-22 g, purchased from Jinan Pengyue Experimental Animal Breeding Co., Ltd., production license number: SCXK (Lu) 20140007.

[0058] Reagent consumables: Potassium oxonate (lot number: B22D9D78194), hypoxanthine (lot number: Y15J9C52922), allopurinol (lot number: X27J10Y91606) were purchased from Yuanye Biology; sodium carboxymethylcellulose (lot number: 20160602), chloroform (Lot No.: 20180808) were purchased from Sinopharm Chemical Reagent Co., Ltd.; XOD (Lot No.: 01 / 2020) ELISA Kit, Jianglai Biotech; RevertAid First Strand cDNA Synthesis Kit (Lot No.: 00775466), American ThermoFisher; Isopropanol ( Batch number: F715BA1004), Shanghai Sangong; TRIzol (batch number: #BCBX0488), Sigma, USA; ChamQ SYBR qPCR Master Mix (batch number: 7E381B9), Nanjing Novizym Biotechnology Co., Ltd.; DEPC treated water (ba...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a tuna oligopeptide powder composition. The tuna oligopeptide powder composition comprises the following components in parts by weight: 25-30 parts of tuna oligopeptide powder, 10-15 parts of fructo-oligosaccharide, 15-20 parts of fish collagen peptide powder, 15-20 parts of Western Indian cherry juice powder and 15-20 parts of honey peach juice powder. 5-10 parts of erythritol, 1-2 parts of a compound sour sweetening agent and 3-4 parts of water-soluble sugar, wherein the water-soluble sugar is fucoidin or chitosan oligosaccharide. The tuna oligopeptide powder composition is used for reducing the uric acid level in serum. The tuna oligopeptide powder composition not only can effectively reduce the serum uric acid level, but also can effectively reduce the serum uric acid level, the main component small molecule peptide is easily absorbed by the human body, the compatibility of various raw and auxiliary materials is helpful for maintaining the health level, notoxic or side effect is caused after long-term eating, the defect of side effects of drugs can be effectively solved, and the human health condition is maintained.

Description

technical field [0001] The invention relates to a tuna oligopeptide powder composition and a preparation method and application thereof, belonging to the technical field of marine fish food processing. Background technique [0002] In recent years, with changes in lifestyle, eating habits, and the surrounding environment, the incidence of gout has been increasing year by year. Gout is a metabolic disease caused by abnormal purine metabolism in the human body, and its biochemical basis is hyperuricemia. Uric acid is the final product of the metabolism of purine substances in the human body. It is slightly soluble in the blood environment of the body. When the production of uric acid is much higher than the excretion, the blood uric acid level in the body continues to rise, and the sodium uric acid crystals are formed when the solubility is higher than the solubility. Deposited in joints, kidneys and other tissues, causing inflammation, severe cases form tophi, eventually lea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A23L33/18A23L33/125A23L33/21A23L33/10A23L27/20A23L27/30A23L27/10A23L19/00C12P21/06C07K14/78C07K1/34
CPCA23V2002/00A23L19/09A23L27/10A23L27/2028A23L27/37A23L33/10A23L33/125A23L33/18A23L33/21C07K1/34C07K14/78C12P21/06A23V2200/30A23V2200/324A23V2200/14A23V2200/16A23V2200/326A23V2200/3262A23V2250/284A23V2250/51A23V2250/6402A23V2250/044A23V2250/032A23V2250/264A23V2250/55A23V2250/262A23V2250/254
Inventor 李亚刘超张娟娟王桂萍牟若楠邓晓影于雁飞
Owner YANTAI JIAHUI MARINE BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap